Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5006 |  SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.23 USD | -8.00% | -20.69% | -32.35% | -85.71% | 1.28 M USD | ||
| 5011 |  VRAX Virax Biolabs Group Limited - Ordinary Shares | 1.99 USD | -5.69% | -11.16% | -27.11% | +192.65% | 1.15 M USD | ||
| 5046 |  SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 1.21 USD | +7.08% | -6.92% | -29.24% | +59.21% | 419.65 K USD | ||
| 5092 |  BDRX Biodexa Pharmaceuticals plc - American Depositary Shares | 0.52 USD | -7.14% | -16.13% | -38.10% | -62.86% | 46.97 K USD | ||
| 5095 |  CDT CDT Equity Inc. - Common Stock | 0.80 USD | -4.76% | -37.50% | +95.12% | +48.15% | 25.17 K USD | ||
| 5100 |  CMND Clearmind Medicine Inc. - Common Shares | 6.60 USD | 0.00% | +816.67% | +560.00% | +573.47% | 13.04 K USD | ||
| 5134 |  GMAB Genmab A/S - American Depositary Shares | 36.05 USD | -1.64% | +4.83% | +11.06% | +13.01% | 0 USD | ||
| 5166 |  OCS Oculis Holding AG - Ordinary shares | 8.66 USD | +1.88% | -1.81% | -23.70% | -59.72% | 0 USD | ||
| 5179 |  ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 USD | +10.39% | -1.59% | +3.61% | +817.75% | 0 USD | ||
| 5250 |  NVO Novo Nordisk A/S | 38.16 USD | -0.26% | +1.38% | -14.44% | -34.90% | 0 USD | ||
| 5466 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1149 USD | -11.62% | -11.62% | 0.00% | +198.44% | 0 USD | ||
| 6285 |  ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -76.19% | 0 USD | ||
| 6408 |  RVMDW Revolution Medicines, Inc. - Warrant | 9.4400 USD | -12.27% | -19.45% | -17.19% | +3142.87% | 40.32 B USD | ||
| 6637 |  NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 12.6500 USD | 0.00% | 0.00% | +1.04% | -39.33% | 2.54 B USD | ||
| 6709 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 3.5600 USD | -1.11% | -12.10% | -11.66% | +917.14% | 1.23 B USD | ||
| 6823 |  YDESW YD Bio Limited - Warrants | 0.5000 USD | -23.08% | -28.57% | +33.33% | -76.30% | 409.87 M USD | ||
| 6953 |  SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 USD | -27.87% | -40.94% | -42.48% | -68.79% | 262.95 M USD | ||
| 7057 |  ENGNW enGene Therapeutics Inc. - Warrants | 0.1700 USD | 0.00% | -32.00% | -5.66% | -79.01% | 119.29 M USD | ||
| 7102 |  FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 17.78 USD | -1.33% | +9.75% | -4.10% | +149.72% | 76.87 M USD | ||
| 7105 |  NTRBW Nutriband Inc. - Warrant | 0.5500 USD | 0.00% | -32.10% | +83.33% | -67.65% | 75.37 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |